MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Serum mucosal chemokine levels in patients with Parkinson disease.

    S. Haji, W. Sako, N. Murakami, Y. Osaki, Y. Izumi (Tokushima, Japan)

    Objective: To investigate the relationship between mucosal chemokines including CXCL14 and CCL28) and impairment in motor/non-motor function among patients with Parkinson’s disease. Background: Parkinson disease…
  • 2019 International Congress

    Metabolic syndrome and insulin resistance in Parkinson’s disease: could they affect motor or cognitive symptoms?

    M. Hussein, A. Khamis, R. Soliman, S. Ali (Beni Suef, Egypt)

    Objective: The objective of this work was to detect the markers of metabolic syndrome and insulin resistance in patients with PD and to study their…
  • 2019 International Congress

    Hydrocephalic presentation of PSP and follow-up after ventricular-peritoneal shunting: Case report

    A. Taskinbayeva, CH. Shashkin, R. Kaiyrzhanov (Almaty, Kazakhstan)

    Objective: To report a patient with a rare clinical phenotype of Progressive Supranuclear Palsy (PSP) and describe 6 months follow-up results after surgical intervention. Background:…
  • 2019 International Congress

    Early Impairment of Chopsticks Skill Predict Atypical Parkinsonism

    YE. Kim, H. Ma, YJ. Kim (Anyang-Si, Republic of Korea)

    Objective: To evaluate the difference of chopsticks skill in early stage of Parkinson’s disease (PD) and atypical parkinsonism (AP) using a questionnaire and simple motor…
  • 2019 International Congress

    The Power of Normal Saline in Reducing Skin Nodules in Apomorphine

    F. Leen, A. Evans, T. Canento, M. Ghaly, C. Wools, B. Cruse, M. Beckley (Melbourne, Australia)

    Objective: This is a poster presentation Background: Continuous apomorphine therapy is a pump delivered infusion via subcutaneous injection for management of advanced therapy in Parkinson's…
  • 2019 International Congress

    Influence of peripheral immune system on cognitive profile in Parkinson’s disease

    L. Magistrelli, E. Storelli, V. Milner, E. Rasini, F. Marino, M. Cosentino, C. Comi (Varese, Italy)

    Objective: To investigate the influence of the peripheral immune profile in the development of cognitive impairment in PD. Background: Dementia is frequent in advanced Parkinson’s…
  • 2019 International Congress

    The Oral Metagenome and Metatranscriptome of Early Stage Parkinson’s Disease and their Relationship with Clinical and Functional Outcome Measures of Motor and Nonmotor Function

    D. Mihaila, J. Donegan, M. Vidal, D. Larocca, R. Ericson, S. Barns, C. Neville, R. Uhlig, F. Middleton (Syracuse, NY, USA)

    Objective: To identify sensitive and specific biomarkers of changes in the oral microbiome of subjects with early stage Parkinson’s Disease and relate these to clinical,…
  • 2019 International Congress

    Investigating the cellular role of LRRK2 in the immune system

    I. Nazish, R. Bandopadhyay (London, United Kingdom)

    Objective: The objective of this project is to investigate the effect of Leucine Rich-Repeat Kinase 2 (LRRK2) dysfunction in the signalling mechanisms in macrophages and…
  • 2019 International Congress

    Postural alterations in patients with Progressive Supranuclear Palsy

    C. Palmisano, M. Todisco, V. Maltese, R. Cilia, N. Pozzi, A. Canessa, M. Canesi, J. Volkmann, C. Frigo, G. Pezzoli, I. Isaias (Würzburg, Germany)

    Objective: Biomechanical assessment of postural imbalance in patients with Progressive Supranuclear Palsy (PSP) Background: PSP is a neurodegenerative disease characterized by early impairment of balance…
  • 2019 International Congress

    Cortical FDG-PET patterns predict long-term motor progression and disability milestones in Parkinson’s disease

    A. Pilotto, A. Imarisio, E. Premi, SP. Caminiti, L. Presotto, A. Sala, R. Turrone, R. Grasso, A. Alberici, B. Paghera, MC. Rizzetti, B. Borroni, D. Perani, A. Padovani (Brescia, Italy)

    Objective: To evaluate the accuracy of single-subject FDG-PET in predicting motor and cognitive long-term progression in Parkinson's disease Background: The progression of Parkinson's disease is…
  • « Previous Page
  • 1
  • …
  • 112
  • 113
  • 114
  • 115
  • 116
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley